Public attitudes on COVID-19 vaccines developed by different countries in China 2020

Published by
Wenyi Zhang,
Jun 14, 2022
A global survey on attitudes towards coronavirus COVID-19 vaccinations found out that Chinese people tended to think more negatively about a COVID-19 vaccine if it was developed in the United States or India. As per the survey results generated in December 2020, about 45 percent of Chinese respondents had a negative impression of the coronavirus vaccines produced in the United States, compared to only 14 percent when it comes to German vaccines.

Public opinion on COVID-19 vaccines developed by different countries in China as of December 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2020

Region

China

Survey time period

7 to 20 December, 2020

Number of respondents

1,016 respondents

Method of interview

Online survey

Supplementary notes

Original survey question:
"Would you tend to think more positively or negatively about a COVID-19 vaccine if you saw that it was developed in each of the following countries, or would it make no difference?"

Percentages may not total 100 due to rounding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Distribution inequality

5

Vaccination approval and willingness

8

Further related statistics

11

Further Content: You might find this interesting as well

Statistics

Topics

Sputnik V COVID-19 vaccineAstraZenecaCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) vaccines and treatmentsCoronavirus (COVID-19) in Russia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.